None listed
Conditions
Interventions
None listed
Sponsors
Kyung Hee University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who were registered in the National Health Insurance database, and whose data (from the time of diagnosis to 2015) can be used for the analysis. 2) Patients who were diagnosed as schizophrenia in 2008-2010 (patients with the F20 code of International Classification of Diseases, 10th Revision (ICD-10)).
Exclusion criteria
Exclusion criteria: 1) Patients who can not be included in the analysis due to missing information of demographics (date of birth, gender, age, etc.) diseases (i.e., name of disease), or prescription (i.e., name of prescribed drug) 2) In the case of patients who were treated with clozapine, the data cannot be included in the analysis when the information required for the analysis (e.g., drug information, average daily dose, total number of days of administration, and so on) is missing.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Use of medications for diabetes and hyperlipidemia in schizophrenia patients | — |
Primary
| Measure | Time frame |
|---|---|
| Current status and trends of the use of antipsychotic drugs in schizophrenia patients | — |
Countries
Korea, Republic of
Contacts
Public ContactSang-In Park
Kyung Hee University
Outcome results
None listed